| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature reviews Gastroenterology & hepatology 13 (5), 261-80, 2016 | 1096 | 2016 |
| Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ... Gastroenterology 152 (8), 1975-1984. e8, 2017 | 480 | 2017 |
| Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis G Svegliati‐Baroni, S Saccomanno, C Rychlicki, L Agostinelli, ... Liver International 31 (9), 1285-1297, 2011 | 465 | 2011 |
| Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ... Nature genetics 42 (8), 658-660, 2010 | 465 | 2010 |
| Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ... The Lancet 391 (10138), 2417-2429, 2018 | 457 | 2018 |
| Wnt–β-catenin signalling in liver development, health and disease MJ Perugorria, P Olaizola, I Labiano, A Esparza-Baquer, M Marzioni, ... Nature reviews Gastroenterology & hepatology 16 (2), 121-136, 2019 | 435 | 2019 |
| Ductular reaction in liver diseases: pathological mechanisms and translational significances K Sato, M Marzioni, F Meng, H Francis, S Glaser, G Alpini Hepatology 69 (1), 420-430, 2019 | 344 | 2019 |
| Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver D Alvaro, MG Mancino, S Glaser, E Gaudio, M Marzioni, H Francis, ... Gastroenterology 132 (1), 415-431, 2007 | 341 | 2007 |
| A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-α and n-3 polyunsaturated fatty acid treatment on … G Svegliati-Baroni, C Candelaresi, S Saccomanno, G Ferretti, T Bachetti, ... The American journal of pathology 169 (3), 846-860, 2006 | 323 | 2006 |
| International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ... Nature communications 6 (1), 8019, 2015 | 309 | 2015 |
| Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice S De Minicis, C Rychlicki, L Agostinelli, S Saccomanno, C Candelaresi, ... Hepatology 59 (5), 1738-1749, 2014 | 286 | 2014 |
| Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma A Arbelaiz, M Azkargorta, M Krawczyk, A Santos‐Laso, A Lapitz, ... Hepatology 66 (4), 1125-1143, 2017 | 274 | 2017 |
| Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical … L Aabakken, TH Karlsen, J Albert, M Arvanitakis, O Chazouilleres, ... Endoscopy 49 (06), 588-608, 2017 | 271 | 2017 |
| Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism E Gaudio, B Barbaro, D Alvaro, S Glaser, H Francis, Y Ueno, ... Gastroenterology 130 (4), 1270-1282, 2006 | 252 | 2006 |
| Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production A Di Sario, E Bendia, GS Baroni, F Ridolfi, A Casini, E Ceni, ... Journal of hepatology 37 (5), 584-591, 2002 | 190 | 2002 |
| Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell‐to‐cell interaction and transition G Svegliati‐Baroni, S De Minicis, M Marzioni Liver International 28 (8), 1052-1064, 2008 | 180 | 2008 |
| Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature Reviews Gastroenterology & Hepatology 13 (5), 261-280, 2016 | 175 | 2016 |
| Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between … BD Juran, GM Hirschfield, P Invernizzi, EJ Atkinson, Y Li, G Xie, R Kosoy, ... Human molecular genetics 21 (23), 5209-5221, 2012 | 173 | 2012 |
| Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway H Francis, S Glaser, S DeMorrow, E Gaudio, Y Ueno, J Venter, D Dostal, ... American Journal of Physiology-Cell Physiology 295 (2), C499-C513, 2008 | 155 | 2008 |
| Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha G Alpini, L Baiocchi, S Glaser, Y Ueno, M Marzioni, H Francis, JL Phinizy, ... Hepatology 35 (5), 1041-1052, 2002 | 154 | 2002 |
